CINGULATE INC (CING) Fundamental Analysis & Valuation

NASDAQ:CING • US17248W3034

Current stock price

5.76 USD
-0.2 (-3.36%)
At close:
5.7 USD
-0.06 (-1.04%)
Pre-Market:

This CING fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CING Profitability Analysis

1.1 Basic Checks

  • In the past year CING has reported negative net income.
  • CING had a negative operating cash flow in the past year.
  • CING had negative earnings in each of the past 5 years.
  • CING had a negative operating cash flow in each of the past 5 years.
CING Yearly Net Income VS EBIT VS OCF VS FCFCING Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of CING (-147.32%) is worse than 85.34% of its industry peers.
  • With a Return On Equity value of -885.07%, CING is not doing good in the industry: 85.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -147.32%
ROE -885.07%
ROIC N/A
ROA(3y)-311.47%
ROA(5y)-235.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CING Yearly ROA, ROE, ROICCING Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CING so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CING Yearly Profit, Operating, Gross MarginsCING Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CING Health Analysis

2.1 Basic Checks

  • CING has more shares outstanding than it did 1 year ago.
  • CING has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CING is higher compared to a year ago.
CING Yearly Shares OutstandingCING Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
CING Yearly Total Debt VS Total AssetsCING Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • CING has an Altman-Z score of -13.34. This is a bad value and indicates that CING is not financially healthy and even has some risk of bankruptcy.
  • CING has a Altman-Z score of -13.34. This is in the lower half of the industry: CING underperforms 79.06% of its industry peers.
  • CING has a Debt/Equity ratio of 2.97. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 2.97, CING is doing worse than 83.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.97
Debt/FCF N/A
Altman-Z -13.34
ROIC/WACCN/A
WACCN/A
CING Yearly LT Debt VS Equity VS FCFCING Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that CING should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.16, CING is doing worse than 82.20% of the companies in the same industry.
  • A Quick Ratio of 1.16 indicates that CING should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.16, CING is doing worse than 76.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
CING Yearly Current Assets VS Current LiabilitesCING Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CING Growth Analysis

3.1 Past

  • CING shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.18%, which is quite impressive.
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 23.21% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y60.54%
EPS Next 2Y32.45%
EPS Next 3Y23.21%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CING Yearly Revenue VS EstimatesCING Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
CING Yearly EPS VS EstimatesCING Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

1

4. CING Valuation Analysis

4.1 Price/Earnings Ratio

  • CING reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CING. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CING Price Earnings VS Forward Price EarningsCING Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CING Per share dataCING EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • CING's earnings are expected to grow with 23.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.45%
EPS Next 3Y23.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CING Dividend Analysis

5.1 Amount

  • CING does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CING Fundamentals: All Metrics, Ratios and Statistics

CINGULATE INC

NASDAQ:CING (4/10/2026, 8:12:42 PM)

Premarket: 5.7 -0.06 (-1.04%)

5.76

-0.2 (-3.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-18
Earnings (Next)N/A
Inst Owners4.47%
Inst Owner Change0%
Ins Owners1.1%
Ins Owner Change2.65%
Market Cap66.76M
Revenue(TTM)N/A
Net Income(TTM)-22.21M
Analysts82.22
Price Target29.33 (409.2%)
Short Float %9.68%
Short Ratio1.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-53.99%
Min EPS beat(2)-63.4%
Max EPS beat(2)-44.58%
EPS beat(4)0
Avg EPS beat(4)-32.77%
Min EPS beat(4)-63.4%
Max EPS beat(4)-1.2%
EPS beat(8)3
Avg EPS beat(8)-28.05%
EPS beat(12)4
Avg EPS beat(12)-26.46%
EPS beat(16)6
Avg EPS beat(16)-22.82%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.71%
PT rev (3m)4.93%
EPS NQ rev (1m)-15.2%
EPS NQ rev (3m)-15.2%
EPS NY rev (1m)-3.43%
EPS NY rev (3m)39.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-100%
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 26.61
P/tB 26.61
EV/EBITDA N/A
EPS(TTM)-4.41
EYN/A
EPS(NY)-1.74
Fwd EYN/A
FCF(TTM)-1.5
FCFYN/A
OCF(TTM)-1.49
OCFYN/A
SpS0
BVpS0.22
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -147.32%
ROE -885.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-311.47%
ROA(5y)-235.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.97%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z -13.34
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)33.61%
Cap/Depr(5y)50.68%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.82%
EPS Next Y60.54%
EPS Next 2Y32.45%
EPS Next 3Y23.21%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.54%
OCF growth 3YN/A
OCF growth 5YN/A

CINGULATE INC / CING Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CINGULATE INC?

ChartMill assigns a fundamental rating of 1 / 10 to CING.


What is the valuation status for CING stock?

ChartMill assigns a valuation rating of 1 / 10 to CINGULATE INC (CING). This can be considered as Overvalued.


Can you provide the profitability details for CINGULATE INC?

CINGULATE INC (CING) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CING stock?

The Earnings per Share (EPS) of CINGULATE INC (CING) is expected to grow by 60.54% in the next year.